Efficient retrovirus-mediated gene transfer to transplantable human bone marrow cells in the absence of fibronectin
Authors:
Open Access
- 1 October 2000
- journal article
- Published by American Society of Hematology in Blood
- Vol. 96 (7) , 2432-2439
Abstract
The low frequency of transplantable hematopoietic stem cells in adult human bone marrow (BM) and other differences from cord blood stem cells have impeded studies to optimize the retroviral transduction of stem cells from adult sources. To address this problem, first a cytokine combination was defined that would both maximize the kinetics of adult BM CD34+CD38− cell mitogenesis and minimize the period of prestimulation required for the transduction of these cells by a MSCV-GFP/neor virus in tissue culture dishes in the absence of fibronectin. Three days of stimulation with flt3-ligand, Steel factor, interleukin (IL)-3, and hyper-IL-6 proved both necessary and sufficient to obtain 83% ± 2% GFP+ CD34+CD38− cells, 75% ± 10% G418-resistant clonogenic progenitors, and 50% ± 20% transduced long-term culture-initiating cells as recovered 48 hours after a single exposure to virus. Moreover, this was accompanied by a several-fold increase in viral receptor (pit-1) messenger RNA transcripts in the target cells. Using this prestimulation protocol, repeated daily exposure to new virus (3×) did not alter the proportion of transduced cells over that obtained with a single exposure. Adult human BM cells able to engraft immunodeficient (NOD/SCID-β2M−/−) mice were also efficiently transduced (10%-20% GFP+ human lymphoid and myeloid cells present 6-8 weeks after transplant) using a 6-day prestimulation and infection protocol. A clinically useful efficiency of retrovirus-mediated gene transfer to transplantable adult human BM stem cells can thus be obtained with a protocol that allows their semisynchronous activation into cycle and concomitant increased expression of virus receptor transcripts before virus exposure.Keywords
This publication has 59 references indexed in Scilit:
- Effect of Changes in Expression of the Amphotropic Retroviral Receptor PiT-2 on Transduction Efficiency and Viral Titer: Implications for Gene TherapyHuman Gene Therapy, 2000
- High-Efficiency Retroviral Transduction of Mammalian Cells on Positively Charged SurfacesHuman Gene Therapy, 2000
- Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrowExperimental Hematology, 1999
- Retrovirus-Mediated Gene Transfer into Human CD34 + 38 low Primitive Cells Capable of Reconstituting Long-Term Cultures In Vitro and Nonobese Diabetic–Severe Combined Immunodeficiency Mice In VivoHuman Gene Therapy, 1998
- Sustained High-Level Reconstitution of the Hematopoietic System by Preselected Hematopoietic Cells Expressing a Transduced Cell-Surface AntigenHuman Gene Therapy, 1997
- Analysis of gene expression in a complex differentiation hierarchy by global amplification of cDNA from single cellsCurrent Biology, 1995
- Expression of CD34 on human B cell precursorsClinical and Experimental Immunology, 1991
- Life span of multipotential hematopoietic stem cells in vivo.Journal of Experimental Medicine, 1990
- Developmental potential and dynamic behavior of hematopoietic stem cellsCell, 1986
- Retroviral Vector-Mediated Gene Transfer into Human Hematopoietic Progenitor CellsScience, 1985